People prescribed the new generation of weight loss drugs may not receive sufficient nutritional guidance to support safe and sustainable weight loss, leaving them vulnerable to nutritional deficiencies and muscle loss, say experts at UCL and the University of Cambridge
Through advanced genetic testing, sophisticated analytics, and exclusive technology licensed from Mayo Clinic, Phenomix delivers personalised insights that empower physicians to optimise obesity treatments
This decline can impair physical function and mobility
The findings affirm that tirzepatide holds promise as a viable treatment approach for managing obesity in such individuals
5 mg tirzepatide vial For a 5 mg vial, the most common reconstitution volume is 1 mL of bacteriostatic water
Always consult your healthcare provider before making changes to your nutrition, exercise, supplement routine, or GLP-1 medication plan.